Alpha6-Containing Nicotinic Acetylcholine Receptors Mediate Nicotine-Induced Structural Plasticity in Mouse and Human iPSC-Derived Dopaminergic Neurons

被引:6
作者
Collo, Ginetta [1 ,2 ]
Cavalleri, Laura [1 ]
Zoli, Michele [3 ]
Maskos, Uwe [4 ]
Ratti, Emiliangelo [5 ]
Pich, Emilio Merlo [6 ,7 ]
机构
[1] Univ Brescia, Sect Pharmacol, Dept Mol & Translat Med, Brescia, Italy
[2] Univ Basel, Dept Biomed, Basel, Switzerland
[3] Univ Modena & Reggio Emilia, Ctr Neurosci & Neurotechnol, Dept Biomed Metab & Neural Sci, Modena, Italy
[4] Inst Pasteur, CNRS UMR 3571, Unite Neurobiol Integrat Syst Cholinerg, Paris, France
[5] Takeda Pharmaceut Int Co, Neurosci Therapeut Area Unit, Cambridge, MA USA
[6] Imperial Coll London, Div Brain Sci, London, England
[7] Takeda Pharmaceut Int, Neurosci Therapeut Area Unit, Zurich, Switzerland
来源
FRONTIERS IN PHARMACOLOGY | 2018年 / 9卷
关键词
neural plasticity; induced pluripotent stem cells; dopaminergic system; nicotine dependence; translational; dendrite outgrowth; alpha-conotoxins; VENTRAL TEGMENTAL AREA; PLURIPOTENT STEM-CELLS; DEVELOPMENTAL REGULATION; PRENATAL EXPOSURE; ALPHA-CONOTOXIN; SUBUNIT; RELEASE; RAT; EXPRESSION; LOCOMOTION;
D O I
10.3389/fphar.2018.00572
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Midbrain dopamine (DA) neurons are considered a critical substrate for the reinforcing and sensitizing effects of nicotine and tobacco dependence. While the role of the a 4 and beta 2 subunit containing nicotinic acetylcholine receptors (alpha 4 beta 2*nAChRs) in mediating nicotine effects on DA release and DA neuron activity has been widely explored, less information is available on their role in the morphological adaptation of the DA system to nicotine, eventually leading to dysfunctional behaviors observed in nicotine dependence. In particular, no information is available on the role of alpha 6*nAChRs in nicotine-induced structural plasticity in rodents and no direct evidence exists regarding the occurrence of structural plasticity in human DA neurons exposed to nicotine. To approach this problem, we used two parallel in vitro systems, mouse primary DA neuron cultures from E12.5 embryos and human DA neurons differentiated from induced pluripotent stem cells (iPSCs) of healthy donors, identified using TH+ immunoreactivity. In both systems, nicotine 1-10 mu M produced a dose-dependent increase of maximal dendrite length, number of primary dendrites, and soma size when measured after 3 days in culture. These effects were blocked by pretreatments with the alpha 6*nAChR antagonists alpha-conotoxin MII and alpha-conotoxin PIA, as well as by the alpha 4 beta 2nAChR antagonist dihydrob beta-erythroidine (DH beta E) in both mouse and human DA neurons. Nicotine was also ineffective when the primary DA neurons were obtained from null mutant mice for either the alpha 6 subunit or both the alpha 4 and alpha 6 subunits of nAChR. When pregnant mice were exposed to nicotine from gestational day 15, structural plasticity was also observed in the midbrain DA neurons of postnatal day 1 offspring only in wild-type mice and not in both null mutant mice. This study confirmed the critical role of alpha 4 alpha 6*nAChRs in mediating nicotine-induced structural plasticity in both mouse and human DA neurons, supporting the translational relevance of neurons differentiated from human iPSCs for pharmacological studies.
引用
收藏
页数:15
相关论文
共 70 条
[1]   Prenatal nicotine exposure decreases the release of dopamine in the medial frontal cortex and induces atomoxetine-responsive neurobehavioral deficits in mice [J].
Alkam, Tursun ;
Mamiya, Takayoshi ;
Kimura, Nami ;
Yoshida, Aya ;
Kihara, Daisuke ;
Tsunoda, Yuki ;
Aoyama, Yuki ;
Hiramatsu, Masayuki ;
Kim, Hyoung-Chun ;
Nabeshima, Toshitaka .
PSYCHOPHARMACOLOGY, 2017, 234 (12) :1853-1869
[2]   Evaluation of emotional behaviors in young offspring of C57BL/6J mice after gestational and/or perinatal exposure to nicotine in six different time-windows [J].
Alkam, Tursun ;
Kim, Hyoung-Chun ;
Hiramatsu, Masayuki ;
Mamiya, Takayoshi ;
Aoyama, Yuki ;
Nitta, Atsumi ;
Yamada, Kiyofumi ;
Nabeshima, Toshitaka .
BEHAVIOURAL BRAIN RESEARCH, 2013, 239 :80-89
[3]   Human induced pluripotent stem cells for modelling neurodevelopmental disorders [J].
Ardhanareeswaran, Karthikeyan ;
Mariani, Jessica ;
Coppola, Gianfilippo ;
Abyzov, Alexej ;
Vaccarino, Flora M. .
NATURE REVIEWS NEUROLOGY, 2017, 13 (05) :265-278
[4]   Pluripotent stem cells in disease modelling and drug discovery [J].
Avior, Yishai ;
Sagi, Ido ;
Benvenisty, Nissim .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2016, 17 (03) :170-182
[5]   Developmental regulation of nicotinic acetylcholine receptors within midbrain dopamine neurons [J].
Azam, L. ;
Chen, Y. ;
Leslie, F. M. .
NEUROSCIENCE, 2007, 144 (04) :1347-1360
[6]  
BENOWITZ NL, 1988, NEW ENGL J MED, V319, P1318
[7]   α6-CONTAINING NICOTINIC ACETYLCHOLINE RECEPTORS IN MIDBRAIN DOPAMINE NEURONS ARE POISED TO GOVERN DOPAMINE-MEDIATED BEHAVIORS AND SYNAPTIC PLASTICITY [J].
Berry, J. N. ;
Engle, S. E. ;
Mcintosh, J. M. ;
Drenan, R. M. .
NEUROSCIENCE, 2015, 304 :161-175
[8]   Varenicline Is a Potent Partial Agonist at α6β2* Nicotinic Acetylcholine Receptors in Rat and Monkey Striatum [J].
Bordia, Tanuja ;
Hrachova, Maya ;
Chin, Matthew ;
McIntosh, J. Michael ;
Quik, Maryka .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 342 (02) :327-334
[9]   Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease [J].
Burbulla, Lena F. ;
Song, Pingping ;
Mazzulli, Joseph R. ;
Zampese, Enrico ;
Wong, Yvette C. ;
Jeon, Sohee ;
Santos, David P. ;
Blanz, Judith ;
Obermaier, Carolin D. ;
Strojny, Chelsee ;
Savas, Jeffrey N. ;
Kiskinis, Evangelos ;
Zhuang, Xiaoxi ;
Kruger, Rejko ;
Surmeier, D. James ;
Krainc, Dimitri .
SCIENCE, 2017, 357 (6357) :1255-+
[10]   Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonists [J].
Capelli, Anna Maria ;
Castelletti, Laura ;
Chen, Yu Hua ;
Van der Keyl, Harjeet ;
Pucci, Luca ;
Oliosi, Beatrice ;
Salvagno, Cristian ;
Bertani, Barbara ;
Gotti, Cecilia ;
Powell, Andrew ;
Mugnaini, Manolo .
BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (02) :313-329